MetLife Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
|
|||||
|
2025
Q1 | $993K | Sell |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $918K | Hold |
|
|||||
|
2024
Q2 | $787K | Buy |
|
|||||
|
2024
Q1 | $887K | Hold |
|
|||||
|
2023
Q4 | $753K | Hold |
|
|||||
|
2023
Q3 | $717K | Hold |
|
|||||
|
2023
Q2 | $782K | Hold |
|
|||||
|
2023
Q1 | $942K | Hold |
|
|||||
|
2022
Q4 | $928K | Sell |
|
|||||
|
2022
Q3 | $909K | Sell |
|
|||||
|
2022
Q2 | $806K | Hold |
|
|||||
|
2022
Q1 | $901K | Buy |
|
|||||
|
2021
Q4 | $525K | Hold |
|
|||||
|
2021
Q3 | $480K | Hold |
|
|||||
|
2021
Q2 | $554K | Sell |
|
|||||
|
2021
Q1 | $589K | Hold |
|
|||||
|
2020
Q4 | $566K | Hold |
|
|||||
|
2020
Q3 | $469K | Hold |
|
|||||
|
2020
Q2 | $534K | Hold |
|
|||||
|
2020
Q1 | $405K | Hold |
|
|||||
|
2019
Q4 | $534K | Hold |
|
|||||
|
2019
Q3 | $618K | Hold |
|
|||||
|
2019
Q2 | $744K | Hold |
|
|||||
|
2019
Q1 | $788K | Hold |
|
|||||
|
2018
Q4 | $747K | Hold |
|
|||||
|
2018
Q3 | $1.13M | Hold |
|
|||||
|
2018
Q2 | $1.35M | Buy |
|
|||||
|
2018
Q1 | $983K | Hold |
|
|||||
|
2017
Q4 | $856K | Buy |
|